Software (non-internet/mobile)
Founded: 2015
Headquarters: Shenzhen, Guangdong
Already have an account? Sign In
iCarbonX, founded in 2015 and headquartered in Shenzhen, China, is a technology company focused on health monitoring and optimization. The company offers a platform and tools for digitizing, analyzing, and understanding life, delivering intelligent products and applications designed to help individuals make smarter choices in the healthcare software sector.
Since its inception, iCarbonX has made significant strides in the health tech industry. The company raised a total of $199 million in funding, including a Series A round in 2016 that valued the company at $1 billion, earning it unicorn status. Notable investors include Tencent and Vcanbio, demonstrating strong confidence in iCarbonX's potential.
As of now, there is no concrete information available regarding iCarbonX's plans for an initial public offering (IPO). The company has not made any official announcements about going public, and we have not found any credible reports or rumors suggesting an imminent IPO.
Several factors could influence iCarbonX's decision to go public in the future, including market conditions, the company's financial performance, and its growth strategy. However, without official statements or reliable information, it's not possible to speculate on the likelihood or timing of an iCarbonX IPO. Investors interested in iCarbonX should continue to monitor official company announcements and credible financial news sources for any updates on potential IPO plans.
Already have an account? Sign In
While iCarbonX's IPO prospects remain uncertain, investors eager to explore opportunities in the AI-driven healthcare space don't have to wait. At Linqto, we offer members access to interests in promising private companies before they go public. Our platform provides the opportunity to invest in potential leaders in the biotech and AI sectors, like iCarbonX, with lower minimum investments than traditional private equity opportunities. This allows you to potentially benefit from the growth of innovative companies reshaping the future of personalized healthcare.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.